Fig. 4From: Platelet-membrane-biomimetic nanoparticles for targeted antitumor drug deliveryMTT viability results for a H22 cells treated with blank PLTM-CS-pPLGA NPs, b H22 cells treated with free bufalin, CS-pPLGA/Bu and PLTM-CS-pPLGA/Bu NPsBack to article page